THR-184: Phase II ongoing
Thrasos said an IDMC recommended continuation of a double-blind, placebo-controlled, North American Phase II trial
Gathering data...
Thrasos said an IDMC recommended continuation of a double-blind, placebo-controlled, North American Phase II trial